Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 27, 2021, reporting its third-quarter 2021 financial results via a press release. While the filing itself does not detail the specific financial figures, it directs investors to the furnished press release for this information. A key development highlighted in the filing is the adjustment of the interest rate on the company's $350 million 7.00% Senior Notes due 2035. Due to credit rating upgrades from Moody's, Fitch, and Standard & Poor's, the interest rate on these notes will decrease from 7.00% to 6.75% effective November 15, 2021. This rate reduction reflects the company's improved creditworthiness and offers a prospective cost saving on its debt. The filing also notes that further credit rating upgrades could lead to additional interest rate decreases, down to a floor of 6.25%.
Key Highlights
- 1Boston Scientific announced its third-quarter 2021 financial results on October 27, 2021, via a press release furnished with the 8-K.
- 2The interest rate on the company's $350 million 7.00% Senior Notes due 2035 will be reduced.
- 3The interest rate decrease from 7.00% to 6.75% is a result of previous credit rating upgrades by Moody's, Fitch, and Standard & Poor's.
- 4The new, lower interest rate will take effect beginning November 15, 2021.
- 5The company's creditworthiness has improved, as evidenced by the rating upgrades.
- 6There is a provision for further interest rate reductions on the 2035 Notes, with a floor of 6.25%, based on future credit rating upgrades.